var data={"name":"Heart failure","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Angiotensin converting enzyme inhibitors","type":"SUBSECTION","items":[{"name":"Angiotensin converting enzyme inhibitors and receptor blockers in heart failure: Mechanisms of action","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=angiotensin-converting-enzyme-inhibitors-and-receptor-blockers-in-heart-failure-mechanisms-of-action"},{"name":"Renal effects of ACE inhibitors in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=renal-effects-of-ace-inhibitors-in-heart-failure"},{"name":"Use of angiotensin converting enzyme inhibitors in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-angiotensin-converting-enzyme-inhibitors-in-heart-failure-with-reduced-ejection-fraction"}]},{"name":"Angiotensin II receptor blockers","type":"SUBSECTION","items":[{"name":"Angiotensin converting enzyme inhibitors and receptor blockers in heart failure: Mechanisms of action","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=angiotensin-converting-enzyme-inhibitors-and-receptor-blockers-in-heart-failure-mechanisms-of-action"},{"name":"Use of angiotensin II receptor blocker in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-angiotensin-ii-receptor-blocker-in-heart-failure-with-reduced-ejection-fraction"}]},{"name":"Asymptomatic left ventricular dysfunction","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of asymptomatic left ventricular systolic dysfunction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-asymptomatic-left-ventricular-systolic-dysfunction"},{"name":"Management and prognosis of asymptomatic left ventricular systolic dysfunction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-and-prognosis-of-asymptomatic-left-ventricular-systolic-dysfunction"}]},{"name":"Cardiomyopathy","type":"SUBSECTION","items":[{"name":"Alcoholic cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=alcoholic-cardiomyopathy"},{"name":"Arrhythmia-induced cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=arrhythmia-induced-cardiomyopathy"},{"name":"Cardiotoxicity of radiation therapy for breast cancer and other malignancies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiotoxicity-of-radiation-therapy-for-breast-cancer-and-other-malignancies"},{"name":"Causes of dilated cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=causes-of-dilated-cardiomyopathy"},{"name":"Clinical manifestations and diagnosis of amyloid cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-amyloid-cardiomyopathy"},{"name":"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-stress-takotsubo-cardiomyopathy"},{"name":"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-diagnosis-and-management-of-the-cardiovascular-complications-of-cocaine-abuse"},{"name":"Echocardiographic recognition of cardiomyopathies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=echocardiographic-recognition-of-cardiomyopathies"},{"name":"Genetics of dilated cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=genetics-of-dilated-cardiomyopathy"},{"name":"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-in-children-clinical-manifestations-and-diagnosis"},{"name":"Hypertrophic cardiomyopathy in children: Management and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-in-children-management-and-prognosis"},{"name":"Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-clinical-manifestations-diagnosis-and-evaluation"},{"name":"Hypertrophic cardiomyopathy: Gene mutations and clinical genetic testing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-gene-mutations-and-clinical-genetic-testing"},{"name":"Hypertrophic cardiomyopathy: Medical therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-medical-therapy"},{"name":"Hypertrophic cardiomyopathy: Morphologic variants and the pathophysiology of left ventricular outflow tract obstruction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-morphologic-variants-and-the-pathophysiology-of-left-ventricular-outflow-tract-obstruction"},{"name":"Hypertrophic cardiomyopathy: Natural history and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hypertrophic-cardiomyopathy-natural-history-and-prognosis"},{"name":"Idiopathic restrictive cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=idiopathic-restrictive-cardiomyopathy"},{"name":"Inherited syndromes associated with cardiac disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inherited-syndromes-associated-with-cardiac-disease"},{"name":"Intermediate- and long-term mechanical circulatory support","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intermediate-and-long-term-mechanical-circulatory-support"},{"name":"Ischemic cardiomyopathy: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ischemic-cardiomyopathy-treatment-and-prognosis"},{"name":"Isolated left ventricular noncompaction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=isolated-left-ventricular-noncompaction"},{"name":"Management and prognosis of stress (takotsubo) cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-and-prognosis-of-stress-takotsubo-cardiomyopathy"},{"name":"Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-ventricular-arrhythmias-in-heart-failure-and-cardiomyopathy"},{"name":"Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=peripartum-cardiomyopathy-etiology-clinical-manifestations-and-diagnosis"},{"name":"Peripartum cardiomyopathy: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=peripartum-cardiomyopathy-treatment-and-prognosis"},{"name":"Primary prevention of sudden cardiac death in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-prevention-of-sudden-cardiac-death-in-heart-failure-and-cardiomyopathy"},{"name":"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=secondary-prevention-of-sudden-cardiac-death-in-heart-failure-and-cardiomyopathy"},{"name":"The management of atrial fibrillation in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-management-of-atrial-fibrillation-in-patients-with-heart-failure"},{"name":"Treatment of amyloid cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-amyloid-cardiomyopathy"},{"name":"Ventricular arrhythmias in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ventricular-arrhythmias-in-heart-failure-and-cardiomyopathy"}]},{"name":"Complications","type":"SUBSECTION","items":[{"name":"Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiorenal-syndrome-definition-prevalence-diagnosis-and-pathophysiology"},{"name":"Cardiorenal syndrome: Prognosis and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiorenal-syndrome-prognosis-and-treatment"},{"name":"High altitude, air travel, and heart disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=high-altitude-air-travel-and-heart-disease"},{"name":"Hyponatremia in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hyponatremia-in-patients-with-heart-failure"},{"name":"Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-ventricular-arrhythmias-in-heart-failure-and-cardiomyopathy"},{"name":"Primary prevention of sudden cardiac death in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-prevention-of-sudden-cardiac-death-in-heart-failure-and-cardiomyopathy"},{"name":"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=secondary-prevention-of-sudden-cardiac-death-in-heart-failure-and-cardiomyopathy"},{"name":"Sleep-disordered breathing in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sleep-disordered-breathing-in-heart-failure"},{"name":"The management of atrial fibrillation in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-management-of-atrial-fibrillation-in-patients-with-heart-failure"},{"name":"Treatment of hypertension in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-hypertension-in-patients-with-heart-failure"},{"name":"Treatment of refractory edema in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-refractory-edema-in-adults"},{"name":"Ventricular arrhythmias in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ventricular-arrhythmias-in-heart-failure-and-cardiomyopathy"}]},{"name":"Diastolic dysfunction","type":"SUBSECTION","items":[{"name":"Cellular mechanisms of diastolic dysfunction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cellular-mechanisms-of-diastolic-dysfunction"},{"name":"Clinical manifestations and diagnosis of heart failure with preserved ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-heart-failure-with-preserved-ejection-fraction"},{"name":"Pathophysiology of heart failure with preserved ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-heart-failure-with-preserved-ejection-fraction"},{"name":"Treatment and prognosis of heart failure with preserved ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-heart-failure-with-preserved-ejection-fraction"}]},{"name":"Etiology","type":"SUBSECTION","items":[{"name":"Actions of angiotensin II on the heart","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=actions-of-angiotensin-ii-on-the-heart"},{"name":"Alcoholic cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=alcoholic-cardiomyopathy"},{"name":"Approach to anemia in adults with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-anemia-in-adults-with-heart-failure"},{"name":"Arrhythmia-induced cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=arrhythmia-induced-cardiomyopathy"},{"name":"Cardiac remodeling: Basic aspects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-remodeling-basic-aspects"},{"name":"Cardiac tumors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-tumors"},{"name":"Cardiovascular effects of hypothyroidism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiovascular-effects-of-hypothyroidism"},{"name":"Causes and pathophysiology of high-output heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=causes-and-pathophysiology-of-high-output-heart-failure"},{"name":"Causes of dilated cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=causes-of-dilated-cardiomyopathy"},{"name":"Epidemiology and causes of heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-causes-of-heart-failure"},{"name":"Heart failure in diabetes mellitus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=heart-failure-in-diabetes-mellitus"},{"name":"Lyme carditis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=lyme-carditis"},{"name":"Maternal adaptations to pregnancy: Physiologic respiratory changes and dyspnea","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=maternal-adaptations-to-pregnancy-physiologic-respiratory-changes-and-dyspnea"},{"name":"Mechanical complications of acute myocardial infarction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mechanical-complications-of-acute-myocardial-infarction"},{"name":"Myocardial dysfunction in end-stage renal disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=myocardial-dysfunction-in-end-stage-renal-disease"},{"name":"Noncardiogenic pulmonary edema","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=noncardiogenic-pulmonary-edema"},{"name":"Pathophysiology of chronic mitral regurgitation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-chronic-mitral-regurgitation"},{"name":"Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=peripartum-cardiomyopathy-etiology-clinical-manifestations-and-diagnosis"},{"name":"Peripartum cardiomyopathy: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=peripartum-cardiomyopathy-treatment-and-prognosis"}]},{"name":"Evaluation","type":"SUBSECTION","items":[{"name":"Approach to acute decompensated heart failure in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-acute-decompensated-heart-failure-in-adults"},{"name":"Cardiac remodeling: Clinical assessment and therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-remodeling-clinical-assessment-and-therapy"},{"name":"Clinical manifestations and diagnosis of advanced heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-advanced-heart-failure"},{"name":"Clinical utility of cardiovascular magnetic resonance imaging","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-utility-of-cardiovascular-magnetic-resonance-imaging"},{"name":"Determining the etiology and severity of heart failure or cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=determining-the-etiology-and-severity-of-heart-failure-or-cardiomyopathy"},{"name":"Endomyocardial biopsy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=endomyocardial-biopsy"},{"name":"Evaluation of the patient with suspected heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-of-the-patient-with-suspected-heart-failure"},{"name":"Exercise capacity and VO2 in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=exercise-capacity-and-vo2-in-heart-failure"},{"name":"Functional exercise testing: Ventilatory gas analysis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=functional-exercise-testing-ventilatory-gas-analysis"},{"name":"Natriuretic peptide measurement in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=natriuretic-peptide-measurement-in-heart-failure"},{"name":"Natriuretic peptide measurement in non-heart failure settings","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=natriuretic-peptide-measurement-in-non-heart-failure-settings"},{"name":"Pathophysiology of cardiogenic pulmonary edema","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-cardiogenic-pulmonary-edema"},{"name":"Predictors of survival in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=predictors-of-survival-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Prognosis of heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-of-heart-failure"},{"name":"Tests to evaluate left ventricular systolic function","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tests-to-evaluate-left-ventricular-systolic-function"},{"name":"Treatment and prognosis of heart failure with preserved ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-heart-failure-with-preserved-ejection-fraction"}]},{"name":"Inotropic agents","type":"SUBSECTION","items":[{"name":"Inotropic agents in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inotropic-agents-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Use of digoxin in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-digoxin-in-heart-failure-with-reduced-ejection-fraction"}]},{"name":"Mechanical support","type":"SUBSECTION","items":[{"name":"Cardiac resynchronization therapy in heart failure: Implantation and other considerations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-resynchronization-therapy-in-heart-failure-implantation-and-other-considerations"},{"name":"Cardiac resynchronization therapy in heart failure: Indications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-resynchronization-therapy-in-heart-failure-indications"},{"name":"Intermediate- and long-term mechanical circulatory support","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intermediate-and-long-term-mechanical-circulatory-support"},{"name":"Overview of cardiac pacing in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-cardiac-pacing-in-heart-failure"},{"name":"Practical management of long-term mechanical circulatory support devices","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=practical-management-of-long-term-mechanical-circulatory-support-devices"}]},{"name":"Myocarditis","type":"SUBSECTION","items":[{"name":"Etiology and pathogenesis of myocarditis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=etiology-and-pathogenesis-of-myocarditis"},{"name":"Treatment and prognosis of myocarditis in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-myocarditis-in-adults"}]},{"name":"Pathophysiology","type":"SUBSECTION","items":[{"name":"Cellular mechanisms of diastolic dysfunction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cellular-mechanisms-of-diastolic-dysfunction"},{"name":"Excitation-contraction coupling in myocardium","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=excitation-contraction-coupling-in-myocardium"},{"name":"Nitric oxide, other hormones, cytokines, and chemokines in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nitric-oxide-other-hormones-cytokines-and-chemokines-in-heart-failure"},{"name":"Pathophysiology of chronic mitral regurgitation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-chronic-mitral-regurgitation"},{"name":"Pathophysiology of heart failure with preserved ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-heart-failure-with-preserved-ejection-fraction"},{"name":"Pathophysiology of heart failure: Left ventricular pressure-volume and other hemodynamic relationships","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-heart-failure-left-ventricular-pressure-volume-and-other-hemodynamic-relationships"},{"name":"Pathophysiology of heart failure: Neurohumoral adaptations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-heart-failure-neurohumoral-adaptations"},{"name":"Role of endothelin in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=role-of-endothelin-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Role of oxidative stress in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=role-of-oxidative-stress-in-heart-failure"},{"name":"Skeletal muscle dysfunction and exercise intolerance in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=skeletal-muscle-dysfunction-and-exercise-intolerance-in-heart-failure"}]},{"name":"Pulmonary edema","type":"SUBSECTION","items":[{"name":"Nesiritide in the treatment of acute decompensated heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nesiritide-in-the-treatment-of-acute-decompensated-heart-failure"},{"name":"Noncardiogenic pulmonary edema","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=noncardiogenic-pulmonary-edema"},{"name":"Treatment of acute decompensated heart failure: Components of therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-acute-decompensated-heart-failure-components-of-therapy"},{"name":"Treatment of acute decompensated heart failure: General considerations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-acute-decompensated-heart-failure-general-considerations"}]},{"name":"Pulmonary hypertension","type":"SUBSECTION","items":[{"name":"Clinical features and diagnosis of pulmonary hypertension in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-and-diagnosis-of-pulmonary-hypertension-in-adults"},{"name":"Pulmonary hypertension in patients with left heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pulmonary-hypertension-in-patients-with-left-heart-failure"},{"name":"The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-epidemiology-and-pathogenesis-of-pulmonary-arterial-hypertension-group-1"},{"name":"Treatment of pulmonary hypertension in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-pulmonary-hypertension-in-adults"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Antithrombotic therapy in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antithrombotic-therapy-in-patients-with-heart-failure"},{"name":"Approach to anemia in adults with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-anemia-in-adults-with-heart-failure"},{"name":"Calcium channel blockers in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=calcium-channel-blockers-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Cardiac rehabilitation in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-rehabilitation-in-patients-with-heart-failure"},{"name":"Cardiac remodeling: Clinical assessment and therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-remodeling-clinical-assessment-and-therapy"},{"name":"Cardiac resynchronization therapy in atrial fibrillation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-resynchronization-therapy-in-atrial-fibrillation"},{"name":"Cardiac resynchronization therapy in heart failure: Implantation and other considerations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-resynchronization-therapy-in-heart-failure-implantation-and-other-considerations"},{"name":"Cardiac resynchronization therapy in heart failure: Indications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cardiac-resynchronization-therapy-in-heart-failure-indications"},{"name":"Clinical manifestations, diagnosis, and management of high-output heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-diagnosis-and-management-of-high-output-heart-failure"},{"name":"Drugs that should be avoided or used with caution in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drugs-that-should-be-avoided-or-used-with-caution-in-patients-with-heart-failure"},{"name":"Emergency care of adults with mechanical circulatory support devices","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=emergency-care-of-adults-with-mechanical-circulatory-support-devices"},{"name":"Guideline adherence and outcomes in coronary heart disease and heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=guideline-adherence-and-outcomes-in-coronary-heart-disease-and-heart-failure"},{"name":"Heart failure self-management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=heart-failure-self-management"},{"name":"Hydralazine plus nitrate therapy in patients with heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hydralazine-plus-nitrate-therapy-in-patients-with-heart-failure-with-reduced-ejection-fraction"},{"name":"Indications and contraindications for cardiac transplantation in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=indications-and-contraindications-for-cardiac-transplantation-in-adults"},{"name":"Inotropic agents in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inotropic-agents-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Intermediate- and long-term mechanical circulatory support","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=intermediate-and-long-term-mechanical-circulatory-support"},{"name":"Investigational and emerging therapies for heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=investigational-and-emerging-therapies-for-heart-failure"},{"name":"Management and prognosis of asymptomatic left ventricular systolic dysfunction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-and-prognosis-of-asymptomatic-left-ventricular-systolic-dysfunction"},{"name":"Management of heart failure during pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-heart-failure-during-pregnancy"},{"name":"Management of refractory heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-refractory-heart-failure-with-reduced-ejection-fraction"},{"name":"Nesiritide in the treatment of acute decompensated heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nesiritide-in-the-treatment-of-acute-decompensated-heart-failure"},{"name":"Nonselective NSAIDs: Adverse cardiovascular effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nonselective-nsaids-adverse-cardiovascular-effects"},{"name":"Overview of cardiac pacing in heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-cardiac-pacing-in-heart-failure"},{"name":"Overview of the therapy of heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-therapy-of-heart-failure-with-reduced-ejection-fraction"},{"name":"Palliative care for patients with advanced heart failure: Decision support, symptom management, and psychosocial assistance","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=palliative-care-for-patients-with-advanced-heart-failure-decision-support-symptom-management-and-psychosocial-assistance"},{"name":"Palliative care for patients with advanced heart failure: Indications and strategies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=palliative-care-for-patients-with-advanced-heart-failure-indications-and-strategies"},{"name":"Perioperative management of heart failure in patients undergoing noncardiac surgery","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=perioperative-management-of-heart-failure-in-patients-undergoing-noncardiac-surgery"},{"name":"Pharmacologic therapy of heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacologic-therapy-of-heart-failure-with-reduced-ejection-fraction"},{"name":"Primary prevention of sudden cardiac death in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-prevention-of-sudden-cardiac-death-in-heart-failure-and-cardiomyopathy"},{"name":"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=secondary-prevention-of-sudden-cardiac-death-in-heart-failure-and-cardiomyopathy"},{"name":"Statin therapy in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=statin-therapy-in-patients-with-heart-failure"},{"name":"Strategies to reduce hospitalizations in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=strategies-to-reduce-hospitalizations-in-patients-with-heart-failure"},{"name":"Surgical management of heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=surgical-management-of-heart-failure"},{"name":"The management of atrial fibrillation in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-management-of-atrial-fibrillation-in-patients-with-heart-failure"},{"name":"Treatment and prognosis of heart failure with preserved ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-heart-failure-with-preserved-ejection-fraction"},{"name":"Treatment of acute decompensated heart failure in acute coronary syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-acute-decompensated-heart-failure-in-acute-coronary-syndromes"},{"name":"Treatment of acute decompensated heart failure: Components of therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-acute-decompensated-heart-failure-components-of-therapy"},{"name":"Treatment of acute decompensated heart failure: General considerations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-acute-decompensated-heart-failure-general-considerations"},{"name":"Treatment of hypertension in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-hypertension-in-patients-with-heart-failure"},{"name":"Treatment of refractory edema in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-refractory-edema-in-adults"},{"name":"Use of angiotensin receptor-neprilysin inhibitor in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-angiotensin-receptor-neprilysin-inhibitor-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Use of beta blockers in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-beta-blockers-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Use of digoxin in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-digoxin-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Use of diuretics in patients with heart failure","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-diuretics-in-patients-with-heart-failure"},{"name":"Use of ivabradine in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-ivabradine-in-heart-failure-with-reduced-ejection-fraction"},{"name":"Use of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-mineralocorticoid-receptor-antagonists-in-heart-failure-with-reduced-ejection-fraction"}]}]}